M. M. Levine

发表

The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS)

Inacio Mandomando, Anowar Hossain, Martin Antonio, 2016, PLoS neglected tropical diseases.

Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans

M. Levine, J. Mekalanos, G. Losonsky, 1988, The Journal of experimental medicine.

Salmonella typhi infection in children younger than five years of age.

M. Levine, W. Mahle, M. M. Levine, 1993, The Pediatric infectious disease journal.

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.

M. Levine, G. Losonsky, J. Nataro, 1995, Vaccine.

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.

M. Levine, C. Simanjuntak, M. Lesmana, 2000, Vaccine.

Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR.

M. Levine, G. Losonsky, T. Nutman, 2000, The Journal of infectious diseases.

Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge.

M. Levine, C. Tacket, G. Losonsky, 1995, The Journal of infectious diseases.

Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O

M. Levine, G. Losonsky, J. Kaper, 1995, Infection and immunity.

Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children.

Suharyono, C. Simanjuntak, N. Punjabi, 1993, The Journal of infectious diseases.

Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels

G. Losonsky, M. Penny, J. Kaper, 1993, Infection and immunity.

A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.

M. Levine, G. Losonsky, C. Plowe, 1998, Bulletin of the World Health Organization.

Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O.

M. Levine, C. Tacket, G. Losonsky, 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.

M. Levine, C. Tacket, G. Losonsky, 1992, The Journal of clinical investigation.

Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.

M. Levine, R. Black, G. Losonsky, 1987, The Journal of infectious diseases.

Molecular epidemiology of Haemophilus influenzae within families in Santiago, Chile.

D. Maneval, M. Levine, J. Musser, 1991, The Journal of infectious diseases.

Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country.

M. Levine, I. Heitmann, O. Levine, 1998, The Pediatric infectious disease journal.

Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity

M. Levine, C. Tacket, G. Losonsky, 1997, Clinical and diagnostic laboratory immunology.

Practical and economical method for using biotinylated DNA probes with bacterial colony blots to identify diarrhea-causing Escherichia coli

M. Levine, J. Kaper, M. Baldini, 1990, Journal of clinical microbiology.

Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containment.

M. Levine, R. Black, J. Kaper, 1983, The Journal of infectious diseases.

Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization.

M. Levine, H. Dupont, R. Gilman, 1976, The Journal of infectious diseases.

Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever.

M. Levine, J. Dumler, R. Black, 1983, The Journal of infectious diseases.

Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries.

M. Levine, G. Mccracken, B. Murray, 1985, The Journal of infectious diseases.

Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri.

M. Levine, H. Dupont, P. Gemski, 1977, The Journal of infectious diseases.

Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli

L. Cisneros, M. Levine, R. Black, 1981, Antimicrobial Agents and Chemotherapy.

Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man.

M. Levine, R. Black, M. Clements, 1982, Scandinavian journal of infectious diseases. Supplementum.

Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli

M. Levine, G. Losonsky, G. Losonsky, 1996, Infection and immunity.

Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children

M. Levine, G. Losonsky, S. Cryz, 1993, Infection and immunity.

The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1

D. Maneval, M. Levine, J. Kaper, 1995, Infection and immunity.